ERBB2 and triple-negative breast carcinoma: We observed no significant differences in MDSCs, PMN-MDSCs or M-MDSCs levels among Luminal A, Luminal B, Her-2 overexpression and triple-negative breast cancer patients, suggesting that the peripheral blood level of MDSCs in breast cancer subtypes.